HomeInsightsStock Comparison

Biocon Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Biocon Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Last Updated on: Jul 09, 2025

Key Highlights

  • The Latest Trading Price of Biocon Ltd is ₹ 374 as of 09 Jul 13:56.
  • The P/E Ratio of Biocon Ltd changed from 43.4 on March 2020 to 31 on March 2024 . This represents a CAGR of -6.51% over 5 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Biocon Ltd changed from ₹ 32472 crore on March 2020 to ₹ 31707 crore on March 2024 . This represents a CAGR of -0.48% over 5 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 1190 crore on March 2020 to ₹ 1340 crore on March 2024 . This represents a CAGR of 2.41% over 5 years.
  • The revenue of Biocon Ltd for the Mar '25 is ₹ 4474 crore as compare to the Dec '24 revenue of ₹ 3874 crore. This represent the growth of 15.49% The revenue of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 278.96 crore as compare to the Dec '24 revenue of ₹ 301.8 crore. This represent the decline of -7.57%.
  • The ebitda of Biocon Ltd for the Mar '25 is ₹ 1135 crore as compare to the Dec '24 ebitda of ₹ 804.7 crore. This represent the growth of 41.11% The ebitda of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 51.32 crore as compare to the Dec '24 ebitda of ₹ 59.17 crore. This represent the decline of -13.27%.
  • The net profit of Biocon Ltd changed from ₹ 148.9 crore to ₹ 459.4 crore over 8 quarters. This represents a CAGR of 75.65% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -19.11 crore to ₹ -2.1 crore over 8 quarters. This represents a CAGR of -66.85% .
  • The Dividend Payout of Biocon Ltd changed from 69.72 % on March 2022 to 50.32 % on March 2024 . This represents a CAGR of -10.30% over 3 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 4.77 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Biocon Ltd

  • Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company.
  • Biocon, with its key business verticals of Generics, Biosimilars, Research Services and Novel Biologics, has leveraged its affordable innovation model and scientific capabilities to develop and manufacture both small and large molecules at global scale for the benefit of patients.
  • At present, Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw.
  • Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.
  • In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International.

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

Biocon Ltd News Hub

News

Biocon schedules board meeting

Biocon will hold a meeting of the Board of Directors of the Company on 7 August 2025. Powe...

Read more

09 Jul 2025 10:55

News

Biocon gets MHRA UK approval for marketing Denosumab biosimilars 'Vevzuo' & 'Evfraxy'

Vevzuo is authorized for the prevention of skeletal related events (pathological fracture,...

Read more

07 Jul 2025 10:27

News

Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars

Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (...

Read more

03 Jul 2025 09:50

News

Biocon Ltd spurts 1.07%, gains for fifth straight session

Biocon Ltd is up for a fifth straight session today. The stock is quoting at Rs 372.5, up ...

Read more

03 Jul 2025 13:00

News

Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'

This approval paves the way for the launch of YESAFILI in Canada, scheduled for 04 July 20...

Read more

27 Jun 2025 12:18

News

Biocon raises Rs 4,500 crore via QIP

Biocon has successfully concluded a Qualified Institutions Placement (QIP), raising Rs 4,5...

Read more

21 Jun 2025 09:13

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma's Ambernath facility clears USFDA inspection

The Agency with their designated investigator inspected the facility from 5th to 9th May 2...

Read more

12 May 2025 08:36

News

Solara Active Pharma Sciences to conduct board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

07 May 2025 17:24

News

Solara Active Pharma Sciences to convene board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

27 Mar 2025 10:23

News

Solara Active Pharma Sciences to hold board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

22 Mar 2025 10:11

News

Solara Active Pharma Sciences to incorporate wholly owned subsidiary

Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in rel...

Read more

07 Feb 2025 11:00

News

Solara Active Pharma Sciences announces board meeting date

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

16 Jan 2025 16:10

SWOT Analysis Of Biocon Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Biocon Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Biocon Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, Biocon Ltd or Solara Active Pharma Sciences Ltd?

Market cap of Biocon Ltd is 49,327 Cr while Market cap of Solara Active Pharma Sciences Ltd is 2,775 Cr

What are the key factors driving the stock performance of Biocon Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of Biocon Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Biocon Ltd and Solara Active Pharma Sciences Ltd?

As of July 9, 2025, the Biocon Ltd stock price is INR ₹368.95. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹623.5.

How do dividend payouts of Biocon Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of Biocon Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions